我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
14
7 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
1
7.1%
已完成
5
35.7%
尚未招募
6
42.9%
招募中
2
14.3%
暂无批准数据
- Mo Haque was diagnosed with stage 4 inoperable bowel cancer in December 2014 and told his chances of successful treatment were small. - After chemotherapy failed and the cancer was deemed terminal, community fundraising of nearly £200,000 enabled access to private immunotherapy in June 2016. - By 2018, there was no evidence of disease in his body, and after ten years of monitoring, he was discharged by his medical team in April 2025. - Haque was later diagnosed with Lynch syndrome, a genetic condition that increases cancer risk, which also made him a candidate for immunotherapy.
